Jeffrey Leathe, CEO & Chairman
Jeffrey Leathe was most recently the Chief Executive Officer and Chairman of the Board at Biocius Life Sciences, a venture backed company involved in developing high throughput instrumentation for mass spectrometry applications in pharmaceutical drug discovery that was acquired by Agilent Technologies. Previously, Mr. Leathe served as the Senior Vice President and Chief Financial Officer of BioTrove Inc., and as Executive Vice President, Chief Financial Officer and Treasurer for Apogent Technologies from 1990-2003.
Mr. Leathe is a director and chairman of the audit committee for Bottomline Technologies, a NASDAQ-listed software firm. He received his MBA from the University of North Carolina, Chapel Hill, his B.S. from the University of New Hampshire and holds his CPA. Watch Technology TV’s interview with Lantos CEO Jeffrey Leathe.
Gary St. Pierre, Vice President and Chief Financial Officer
Gary St. Pierre has held senior finance executive positions in both large public and small private companies, most recently the Chief Financial Officer for BIOCIUS Life Sciences, Inc. Previously, Mr. St.Pierre held senior financial executive positions at BioTrove, Inc., Pelican Life Sciences, Axcelis Technologies and Apogent Technologies.
Mr. St. Pierre has a bachelor’s degree in Economics from Dartmouth College and an Executive MBA from the University of New Hampshire.
Lora Allemeier, Vice President of Product Strategy and Regulatory Affairs
Ms. Allemeier has held senior level global product development, strategic planning, and marketing roles with pharmaceutical and medical device companies. Most recently, she was Head of Global Marketing and Head of Global Regulatory Affairs for Cochlear, based in Sydney, Australia, where she had extensive experience in working with audiologists, ENTs and the hearing market to develop and launch new products globally, including in emerging markets. Previously, she held a variety of senior level marketing, business development, product development and program management positions at GlaxoSmithKline, Stryker, and Eli Lilly, as well as the start-up GMP Companies.
Ms. Allemeier received her MBA from the Indiana University Kelley School of Business and her bachelor’s degree from the Johns Hopkins University.
Jennifer M Rossi, Vice President of Marketing
Dr. Rossi is the Vice President of Marketing at Lantos Technologies. Jennifer has held senior marketing and strategy roles in a variety of life science and technology companies, in recent years focusing on marketing start-up and spin-out companies. Prior to joining Lantos, Dr. Rossi was the VP of Marketing and Corporate Communications at BIOCIUS Life Sciences, which was sold to Agilent Technologies following its successful spin-out from BioTrove, Inc. Previously Jennifer was Director of Sales and Marketing for 5Prime, Global Marketing Manager at Qiagen and Global Product Manager at Cohesive Technologies (acquired by ThermoFisher).
Dr. Rossi received her Ph.D. from Brown University in Biochemistry and Molecular Biology where she studied hepatic stem cells, and her BS/MS in Biology from Ohio University’s Honors Tutorial College. She is a Board member of the Charlestown Mother’s Association, a non-profit organization which seeks to improve the historic Charlestown neighborhood of Boston.